A4 Study: Testing Solanezumab before Alzheimer’s Symptoms Appear

Healthy older adults with no symptoms of Alzheimer’s disease are the focus of a large study involving 61 medical centers across the U.S., Canada and Australia. The Anti-Amyloid Treatment in Asymptomatic Alzheimer’s study aims to find out if Eli Lilly’s solanezumab, which failed in earlier studies to help people with Alzheimer’s symptoms, will help prevent Alzheimer’s if given long before symptoms appear. Solanezumab...

Source: Carol Bradley Bursack's SharePosts - June 26, 2014 Category: Dementia Authors: Carol Bradley Bursack Source Type: blogs